The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes.

Yan, M

The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. [electronic resource] - FASEB journal : official publication of the Federation of American Societies for Experimental Biology May 2001 - 1132-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0892-6638

10.1096/fj.00-0601com doi


Acetylcysteine--chemistry
Animals
Anti-Inflammatory Agents--pharmacology
Ataxia Telangiectasia--genetics
Ataxia Telangiectasia Mutated Proteins
Cell Cycle--drug effects
Cell Cycle Proteins
Cells, Cultured
DNA--genetics
DNA-Binding Proteins
Dexamethasone--pharmacology
Female
Flow Cytometry
Free Radical Scavengers--chemistry
Humans
Immunosuppressive Agents--pharmacology
Lymphocytes--cytology
Male
Mice
Mitogens--pharmacology
Oxidation-Reduction
Phosphatidylinositol 3-Kinases--genetics
Protein Serine-Threonine Kinases--genetics
Spleen--cytology
Tacrolimus--pharmacology
Thymidine--genetics
Thymus Gland--cytology
Tumor Suppressor Proteins